Get started
Author

Tina Levstek

Observed names: Levstek Tina, Levstek, Tina, Levstek, Tina, farmacevtka
ORCID: 0000-0001-8808-1084
Observed ORCID: 0000-0001-8808-1084
OpenAlex ID: A5010841535
Telomere Attrition in Neurodegenerative Disorders
2020 · Tina Levstek, Eva Kozjek, et al. · Frontiers in Cellular Neuroscience · 52
PDF
Biomarkers of Fabry Nephropathy: Review and Future Perspective
2020 · Tina Levstek, Bojan Vujkovac, et al. · Genes · 34
PDF
Telomere Attrition in Chronic Kidney Diseases
2023 · Tina Levstek, Katarina Trebušak Podkrajšek · Antioxidants · 28
PDF
Urinary-derived extracellular vesicles reveal a distinct microRNA signature associated with the development and progression of Fabry nephropathy
2023 · Tina Levstek, Bojan Vujkovac, et al. · Frontiers in Medicine · 16
Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors
2023 · Tina Levstek, Tina Karun, et al. · Genes · 14
PDF
The Influence of Treatment with PCSK9 Inhibitors and Variants in the CRP (rs1800947), TNFA (rs1800629), and IL6 (rs1800795) Genes on the Corresponding Inflammatory Markers in Patients with Very High Lipoprotein(a) Levels
2022 · Tina Levstek, Nik Podkrajšek, et al. · Journal of Cardiovascular Development and Disease · 14
PDF
Assessment of the Telomere Length and Its Effect on the Symptomatology of Parkinson’s Disease
2021 · Tina Levstek, Sara Redenšek, et al. · Antioxidants · 14
PDF
Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy
2021 · Tina Levstek, Teo Mlinšek, et al. · Genes · 13
PDF
Engineering of extracellular matrix from human iPSC-mesenchymal progenitors to enhance osteogenic capacity of human bone marrow stromal cells independent of their age
2023 · Dominik Hanetseder, Tina Levstek, et al. · Frontiers in Bioengineering and Biotechnology · 12
Haplotype of the Lipoprotein(a) Gene Variants rs10455872 and rs3798220 Is Associated with Parameters of Coagulation, Fibrinolysis, and Inflammation in Patients after Myocardial Infarction and Highly Elevated Lipoprotein(a) Values
2024 · Sabina Ugovšek, Andreja Rehberger Likozar, et al. · International Journal of Molecular Sciences · 7
PDF
Telomere Length, Oxidative Stress, and Kidney Damage Biomarkers in Fabry Nephropathy
2025 · Tina Levstek, Erazem Bahčič, et al. · Cells · 4
PDF
Transcriptomic Approach in Understanding Fabry Nephropathy: A Review of the Literature and Proof-of-Concept
2025 · Nika Breznik, Tina Levstek, et al. · Genes · 3
PDF
Treatment with PCSK9 inhibitors influences microRNAs expression and changes of arterial wall properties: a randomized controlled trial
2025 · Andreja Rehberger Likozar, Tina Levstek, et al. · European journal of medical research · 3
Identification of genetic variants associated with Fabry nephropathy progression using whole-exome sequencing
2025 · Tina Levstek, Bojan Vujkovac, et al. · Molecular Genetics and Metabolism · 2
Dynamics of Leukocyte Telomere Length in Patients with Fabry Disease
2024 · Tina Levstek, Nika Breznik, et al. · Biomedicines · 2
PDF
Proprotein convertase subtilisin/kexin type 9–CC-motif chemokine ligand 2 interactions link lipoprotein(a) composition to intermediate monocyte inflammation in coronary artery disease
2026 · Sabina Ugovšek, Andreja Rehberger Likozar, et al. · Atherosclerosis Plus · 1
Abstract 16485: Treatment With PCSK9 Inhibitors Influence miRNAs Expression and Changes of Arterial Wall Properties
2023 · Andreja Rehberger Likozar, Sabina Ugovšek, et al. · Circulation · 1
Klinična biokemija in laboratorijska diagnostika
2026 · Katarina Trebušak Podkrajšek, Tina Levstek, et al.
PCSK9 Inhibitors Increase CD34+ But Not Other Endothelial Progenitor Cells in Patients with Chronic Coronary Disease and Increased Lp(a) Values
2026 · Sabina Ugovšek, Andreja Rehberger Likozar, et al. · TH Open
PDF
Wcn26-3754 Nmr-based Metabolomic Profiling Reveals Distinct Metabolic Signatures Associated With the Development and Progression of Fabry Nephropathy
2026 · Nika Breznik, Klemen Pečnik, et al. · Kidney International Reports
A non-coding signature in SHROOM3 is associated with kidney disease progression in Fabry disease
2026 · Katarina Trebusak Podkrajsek, Nika Breznik, et al. · Molecular Genetics and Metabolism
A non-coding signature in SHROOM3 is associated with kidney disease progression in Fabry disease
2025 · Tina Levstek, Nika Breznik, et al. · Molecular Genetics and Metabolism
Abstract 4365891: PCSK9 inhibitors increase CD34+ but not other endothelial progenitor cells in patients with stable coronary heart disease and increased Lp(a) values
2025 · Sabina Ugovsek, Andreja Rehberger Likozar, et al. · Circulation
Abstract 4365619: Lipoprotein(a) particle characteristics and PCSK9 determine the monocyte subtype distribution in patients with increased Lp(a) levels
2025 · Sabina Ugovsek, Andreja Rehberger Likozar, et al. · Circulation
Gain of function variants in PCSK9 gene in high risk patients after myocardial infarction with increased lipoprotein (a) values and treated with statins
2025 · Sabina Ugovšek, Andreja Rehberger Likozar, et al. · Scientific Reports
PDF
Works count: 36
Citation count: 220
H-index: 9
I10-index: 9
Year
Topic
Type